Promising ‘Liquid Biopsies’ May Not Be Ready for Primetime—Undark
Source ↗
👁 1
💬 0
Read article—Steven Woloshin, a professor of health policy and clinical practice, comments on technologies in cancer screenings and how the public should know if the benefits of the tests outweigh the risks.
Comments (0)